Toujeo insulin, a long-acting basal insulin, is available in various forms and strengths, impacting its cost. The price can vary significantly based on the dosage, quantity, and where it is purchased, such as through a pharmacy, a hospital, or a direct-to-consumer program.
How Much Does a Toujeo Pen Typically Cost?
A single Toujeo SoloStar pen, which contains 1.5 mL of insulin glargine (300 units/mL), can range in price. For instance, one pen might cost approximately $119.19 at some pharmacies [1]. A package containing multiple pens will have a proportionally higher cost.
What Factors Influence Toujeo's Price?
The price of Toujeo is influenced by several factors. These include whether a patient is using insurance, the specific insurance plan's formulary and copay requirements, and the availability of manufacturer coupons or patient assistance programs. Without insurance, the out-of-pocket cost for Toujeo can be considerably higher. For example, a prescription for Toujeo might cost around $400 to $500 without insurance [1].
Are There Ways to Reduce the Cost of Toujeo?
Patients seeking to lower the cost of Toujeo may explore several avenues. Sanofi, the manufacturer of Toujeo, offers savings programs that can reduce out-of-pocket expenses. These programs can bring the cost down to as low as $0 or a flat copay for eligible commercially insured patients [2]. Additionally, comparing prices at different pharmacies and inquiring about generic alternatives, if available and appropriate, could also lead to cost savings.
When Does Toujeo's Patent Protection End?
Information regarding the specific patent expiry dates for Toujeo is available on specialized databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Toujeo [3]. Understanding patent timelines is crucial for anticipating when generic versions might become available, which could potentially lower the drug's overall cost.
How Does Toujeo Compare to Other Basal Insulins?
Toujeo (insulin glargine 300 units/mL) is a long-acting basal insulin that offers a duration of action of over 24 hours [4]. It is designed to provide steady glucose control and is a higher concentration formulation compared to its predecessor, Lantus (insulin glargine 100 units/mL). The choice between different basal insulins often depends on individual patient needs, treatment goals, and cost considerations.
---
1. https://www.goodrx.com/toujeo
2. https://www.toujeo.com/savings-and-support/toujeo-savings-card.html
3. https://drugpatentwatch.com/
4. https://www.toujeo.com/about-toujeo/how-toujeo-works.html